Abstract : There is an increasing number of patients with severe liver disease that requires whole organ transplantation or living-related split liver transplantation. This has resulted in a shortage of donor organs, which is particularly problematic and still awaits resolution. Bioarti cial liver BAL support systems have been developed with the aim of supporting patients with life-threatening liver disease until their liver recovers. Here, we describe a high performance three-dimensional rat hepa tocyte culture system using a radial-ow bioreactor RFB with a polyvinyl alcohol PVA membrane as a small-scale BAL support system. Hepatocytes from male Sprague-Dawley rat livers were isolated and divided into two groups as follows. Group A : isolated hepatocytes were maintained in culture medium as controls ; and group B : isolated hepatocytes were injected into the medium cham ber of the RFB-PVA culture system. Sampling was carried out every 48 h to ana lyze the concentrations of ammonia and albumin in the medium. Light and elec tron microscopic examination of hepatocytes explanted from the PVA membrane was also performed. Albumin production and urea synthesis by cells in group B were both signi cantly higher than in group A. Hematoxylin-Eosin staining of the cells in group B showed that three-dimensional cell masses were attached to the PVA membrane. It also showed that the cells were stably proliferating in the porous spaces of the PVA. Scanning electron microscopic images of group B also showed clusters of hepatocytes attached to the PVA membrane. Hepatocyte clus ters growing in the RFB-PVA culture system retained their biological function and were stable in the porous spaces of the PVA membrane. This cell culture system may be useful for the development of new BAL support systems.
Introduction
Acute liver failure ALF is a signi cant health problem that is increasing in incidence in Japan. It is frequently characterized by rapid deterioration that leads to coma and death. The only effec tive therapy is liver transplantation. Increased numbers of patients with liver disease as well as expanding indications have led to an increase in the number of liver transplants. This has resulted in a chronic worldwide shortage of donor livers and an increase in both the waiting time and the mortality rate for prospective transplant recipients.
Liver function support strategies have been developed because of the scarcity of donor organs. These strategies aim to support patients with borderline functional liver cell mass either until an appropriate transplantable organ becomes available or until the liver recovers from injury [1] [2] [3] [4] [5] [6] [7] [8] .
Examples of non-biological systems that have been developed include plasma exchange [9] [10] [11] [12] , albumin dialysis [13] [14] [15] , hemo dia ltration [16] [17] [18] , and sorbent-based devices [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . These systems are able to remove the toxins that accumulate because of hepatic failure, but their utility is limited by their inability to provide some liver-speci c functions. In contrast, hepatocyte-based devices are able to provide whole liver function, including detoxi cation, biosynthesis, and biotransformation 5, 26, 27 . The development of clinically effective bioarti cial liver BAL devices requires a high-density device that contains highly functional, viable cells. The function of cultured hepatocytes can improve when they are grown as a three-dimensional 3D culture rather than as a monolayer. The 3D culture conditions more closely resemble the normal tissue environment than those in culture dishes. We used a radial-ow bioreactor RFB to create 3D culture conditions. The RFB is a cylindrical culturing reactor lled with a solid matrix. The medium is pumped from the periphery toward the reactor center at an increasing rate, which is suf cient to supplement the cells with oxygen and nutrients. The matrix consists of a polyvinyl-alcohol PVA membrane with a high pore density that allows for a large surface area for cell attachment and the reduction of shear force caused by direct ow of the medium toward the cells [28] [29] [30] [31] [32] .
In this study, we investigated the functional performance of a small-scale 3D culture system for hepatocytes using a RFB with a PVA membrane.
Materials and methods

Chemicals
Dulbecco s Modi ed Eagle medium DMEM , Hepes, bovine serum albumin BSA , galactose, L-proline, nicotinamide, ascorbic acid, dexamethasone, fetal bovine serum FBS , trypsin-EDTA, calcium chloride, sodium alginate, and phosphate-buffered saline PBS were purchased from Sigma Chemical Co. St. Louis, MO, USA . Rat tail collagen type I was purchased from Col laborative Biomedical Product, Bedford, MA, USA . Penicillin and streptomycin PC / ST were purchased from Omega Scienti c Tarzana, CA, USA . Recombinant human epidermal growth factor rhEGF was purchased from R&D Minneapolis, MN, USA . Insulin-TransferrinSelenium ITS was purchased from Gibco BRL San Francisco, CA, USA . NaCl, KCl, NaHCO 3 , and NaH 2 PO 4 were purchased from Wako Chemical Co Tokyo, Japan .
Animals
This study was approved by the Committee on Animal Ethics in the Care and Use of Laboratory Animals of the Showa University Medical School. Male Sprague-Dawley rats Saitama Experimental Animals Supply Co., Ltd, Saitama, Japan weighing approximately 200-250 g were housed for more than 1 week with 12-h light / dark cycles prior to surgery. Animals were housed in a climate controlled 21 room with a 12-h light / dark cycle and were given tap water and standard laboratory rat chow ad libitum. All operations were performed under general anesthesia ether using a sterile surgical technique.
Hepatocyte isolation
Hepatocytes were harvested by a two-step EDTA / collagenase digestion in situ, as described previously 33 . Brie y, under general anesthesia and portal vein cannulation, in vivo perfusion of the liver was performed with an EDTA / collagenase solution at 37 . The liver was excised and transferred to a culture dish containing DMEM supplemented with 10% FBS at 4 . The capsule was peeled back from all lobes and the tissue was gently combed to isolate and suspend hepatocytes in the DMEM solution. Hepatocytes were filtered through mesh, suspended in DMEM solution and centrifuged at 50 g for 5 min. The cell viability as assessed by the trypan blue exclusion test was greater than 80% after enrichment through a Percoll density gradient.
Radial ow bioreactor
RFBs with either a 5 ml or 30 ml capacity as well as the RFB culture system were used in this study ABLE Corporation, Tokyo, Japan 32, 34, 35 . Porous PVA resin Muromachi Kagaku, Tokyo, Japan was used as the scaffold in the RFB Fig. 1A . The inner space for the scaffold in the 5-ml RFB employed a central spiral coil with a circulation of 3 mm, and was lled with porous PVA resin. Isolated cells were injected into the medium chamber of the RFB culture system, which was lled with DMEM supplemented with 10% FBS pH 7.6 . The medium was circulated between the RFB and the medium chamber using a circulation pump Fig. 1B . The cells remained attached to and grew on the scaffold while the medium was circulated. The concentration of ammonia was assayed using a urea nitrogen diagnostic kit Biopharmigen in samples of medium taken at 48 h intervals. The albumin concentration in the medium is measured using the Rat Albumin Enzyme Immunoassay Kit Maassy Cedex .
Floating culture A floating culture system was used to culture hepatocytes SCHOTT Nippon K.K, Tokyo, Japan using a 100 ml medium bottle and a magnetic stirrer spinning at a rate of 150-200 rpm Fig. 1C . Hepatocytes were suspended in the culture medium, which allowed the 3D cell culture to proceed.
Measurement of albumin secretion
Aliquots of culture medium were collected at 1, 3, 5, and 7 days of culture and the albumin concentration was assayed using a competitive enzyme linked immunosorbent assay ELISA using the Rat Albumin Enzyme Immunoassay Kit. Briefly, samples and the standard were seeded respectively into a 96-well microplate. Whereupon 0.05 ml of rat albumin AchE together with 0.05 ml rat albumin antiserum was added to each well. The plate was covered with plastic lm and incubated for 16 h at 4 . Ellman s Reagent 0.2 ml was then added to the wells, which were incubated with shaking on an orbital shaker in the dark at room temperature for 20-30 min. The absorbance of each well was read between 405 nm and 414 nm Wellreader SME 3400 of Iwaki Glass Co., Ltd, Shizuoka, Japan and the albumin concentration was calculated.
Measurement of urea nitrogen synthesis
A nal concentration of 2.0 mm ammonium chloride was added to the culture medium at 1, 3, 5, and 7 days. After incubation for 6 h, the urea nitrogen concentration was measured using a urea nitrogen diagnostic kit Biopharmigen and the absorbance was measured using a spectrophotometer UV-1200, Shimadzu Co., Ltd, Kyoto, Japan to determine urea synthesis. 
Histological studies
Explanted hepatocytes from the PVA membrane were xed in 10% formaldehyde for histological examination. Light microscopy was performed on paraf n-embedded sections stained with hematoxylin-eosin H-E and periodic acid-Schiff PAS stain.
Immunohistochemical staining of albumin
The hepatocytes were cultured on the PVA scaffold in the 5 ml RFB and the scaffolds were then removed from the reactor and xed with 20% formalin neutral buffer solution pH 7.4 ; Wako Chemicals, Osaka, Japan at 4 for 1 h. The cells on the scaffold were washed twice with PBS, and dehydrated by treatment with a series of solutions with increasing concentrations of ethanol. The dehydrated cell-scaffold material was embedded in resin using the Historesin Plus Embedding Kit Leica, Heidelberg, Germany . Sections of 5 µm thickness were prepared and each section was stained with toluidine blue and observed under a microscope BF-50 ; Olympus, Tokyo, Japan .
Ultrastructual examination
After removing the cultured hepatocytes, the ultrastructure of the PVA membrane was examined using scanning electron microscopy SEM . The PVA membranes were treated for SEM analysis by xation with 2 % glutaraldehyde pH 7.4 at 4 for 24 h. The membranes were then washed and the post-xed cells were dehydrated through a graded alcohol series, dried in hexamethyldisilazane and sputter coated with gold palladium and examined in a VE-7800 Keyence SEM.
Statistical analysis
Values are expressed as mean standard deviation. Statistical signi cance of the differences between the two groups was determined using Student s t-test.
Results
Hepatocyte function in the RFB and the oating culture system
This study cultured hepatocytes in either a 5 ml RFB using a PVA scaffold or a floating culture system and assessed the cellular function of the hepatocytes under these conditions by measuring the synthesis of albumin and urea. A time course of albumin concentration in the hepatocyte RFB-PVA culture system compared to the oating culture system showed signi cantly higher albumin production in the RFB-PVA culture system at all time points examined Fig. 2 . Urea synthesis by hepatocytes in the RFB-PVA culture system was also signi cantly higher than in the oating culture system at all time points examined Fig. 3 .
Morphological features
Thin sections of the scaffolds were prepared after hepatocyte culture and were studied microscopically. Representative photomicrographs of the sections show 3D aggregates of cells attached to the PVA membrane, and demonstrate that the cells were proliferating stably in the porous spaces of the PVA Fig. 4A . Immunohistochemical studies showed that hepatocytes cultured in the RFB-PVA culture system expressed PASs and Albumin at least 7 days after cultivation Figs. 4B, C .
Electron microscopy
A representative SEM image shows the PVA membrane alone Figs. 5A, B and well-attached clustered hepatocytes on the PVA membrane Figs. 5C, D . The hepatocytes cultured in the RFB-PVA culture system formed cell clusters that were 80-200 mm in diameter. These cell clusters grew within the pores of the PVA membrane over a period of 3 days Fig. 5D and were equally distributed throughout the scaffold Fig. 5C . 
Discussion
ALF is a severe disease that, despite recent therapeutic advances, remains associated with signi cant morbidity and mortality. Recently, liver transplantation has become a remarkably effective life-saving treatment for patients with fulminant hepatic failure and end-stage chronic liver disease [1] [2] [3] [4] [5] . Increases in both the number of liver transplantation procedures and the indications for the procedure have resulted in a chronic worldwide shortage of organs for transplantation. This is the situation despite alternative techniques being employed such as split-liver and living donor transplantation. As a result, waiting times and mortality for prospective transplant recipients have also increased. One possible alternative to transplantation in some patients is the BAL support system, which can provide provisional hepatic function until a transplantable liver becomes available. In the present study, we tested the development of a small-scale BAL support system using a PVA membrane for the 3D culture of hepatocytes in a RFB. Primary rat hepatocytes actively survived and formed cell clusters in the porous scaffolds more ef ciently than in a oating culture system. The cultured hepatocytes exhibited excellent cellular function as evidenced by the synthesis of albumin and urea in the RFB-PVA culture system. Hepatocytes cultivated for 7 days in the RFB-PVA culture system secreted an eight-fold greater amount of albumin and a ve-fold greater amount of urea than in the oating culture system.
Various types of bioreactors have been developed to support the growth of high-density 3D cell cultures. In particular, cultures using either microcarriers [41] [42] [43] [44] or hollow-ber modules 31, 45, 46 have been described. In 2004, Demetriou et al reported the development of the HepatAssist BAL device 26 . An early version of the HepatAssist was the first BAL device tested in FDA-approved phase I / II / III clinical trials Arbios Systems, Inc., Pasadena, CA, USA . The HepatAssist BAL device incorporated collagen-coated dextran microcarriers that provided the hepatocytes with an attachment surface. RFBs are one type of bioreactor that can be used for high-density 3D cell culture. In the RFB, liquid medium ows convergently from the periphery to the center Fig.  1A , enabling equally ef cient gas and nutrient exchange in different parts of the scaffold. The use of RFBs can enhance the cellular function of the cultured cells 34, 35 . Hongo et al demonstrated that the cell density in the RFB was 4-15 fold higher than in microcarrier or hollowber cultures 32 .
In this study, we focused on using an RFB that enables the growth of a highly functional 3D culture. The performance of RFBs largely depends on the inclusion of a scaffold to provide a support matrix for cell attachment. Miyoshi et al found that fetal liver cells could be cultivated at high density on a polyvinyl foam PVF resin 47 . They were able to maintain a high-density cell culture 7 10 7 cells / cm 3 over 30 days of culture and the functioning of the cells was assayed by measuring the albumin production rate. They noted that after the rst two weeks the rate of albumin production rate 47 . Kataoka et al developed a new porous organic inor ganic hybrid scaffold consisting of tetraethoxysilane TEOS and polydimethylsiloxane PDMS and employed a sol-gel method with sieved sucrose particles that acted as a porogen 35 . This hybrid material was more suitable than PVA scaffolds to support the culture of the human HepG2 hepatocellular carcinoma cell line that was used in that study. We propose that primary hepatocytes should be used as a cell source rather than a transformed cell line such as HepG2 because cell lines are likely to have a reduced level of liver-speci c function. In a preliminary study, we used two other types of scaffolds in the RFB, with porous beads composed of either silica or hydroxyapatite 32 . Primary hepatocytes could not attach to beads made from either of these materials data not shown . Therefore, we selected a PVA membrane for as a solid support to culture primary hepatocytes in the RFB. In this study, we observed the synthesis of albumin and urea by primary hepatocytes grown in the RFB-PVA culture system, which represents the appropriate functioning of these cells. Thin sections of the scaffolds were examined microscopically, with H-E sections showing that cells were stably attached to the 3D PVA membrane, and these cells were proliferating in the porous spaces of the PVA. Moreover, SEM images showed clustered hepatocytes attached to the PVA membrane. Therefore, we propose that hepatocytes and hepatocyte-derived cell lines exhibit improved speci c cellular functions in cell clusters formed in the RFB with a PVA membrane than in other systems tested to date.
As our understanding of the pathophysiology of liver failure improves, we propose that the RFB system will continue to be developed. This system should provide : i detoxification ;
ii replenishment of specific liver functions ; and iii stimulation of hepatic regeneration in combinations that are appropriate for the individual patient. The RFB-PVA BAL could be used to treat various forms of liver failure or patients with liver failure at various stages of illness. Further studies of this promising technology are required to assure that it can be scaled-up to provide a clinically-useful treatment option.
